- Product Details
Keywords
- Empagliflozin
- 864070-44-0
- API
Quick Details
- ProName: Empagliflozin
- CasNo: 864070-44-0
- Molecular Formula: C23H27ClO7
- Appearance: Off white solid
- Application: pharmaceutical intermediates
- DeliveryTime: Within ten working day
- PackAge: 1KG;10KG;100KG
- Port: Shang hai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 99%
- Storage: Keep container closed and store in coo...
- Transportation: by sea or by air
- LimitNum: 100 Gram
Superiority
summary
Epallegin is a type 2 sodium glucose cotransporter inhibitor developed by bringer Ingelheim and Eli Lilly.
Sglt-2 inhibitor is a new type of hypoglycemic drug. It can reduce the reabsorption of glucose in kidney and increase the excretion of glucose in urine by inhibiting the expression of sglt-2 in the kidney, so as to reduce the plasma glucose level. Its hypoglycemic effect does not depend on the function of β - cell and insulin resistance.
application
Epallegin is used to improve glycemic control in adults with type 2 diabetes mellitus whose diet combined with exercise fails to achieve adequate glycemic control.
Details
COMPANY INTRODUCTION
JIN DUN CHEMICAL belongs to JIN DUN GROUP. It is a professional enterprise dedicated to the development and production of special (meth)acrylate monomers. The head office is located in Shanghai city, near Hongqiao airport.The R&D center of JIN DUN is located in Ningbo city, Zhejiang province.
JIN DUN CHEMICAL focus on the coating, automobile, electricity and pharmaceutical area, always try best to be the professional supplier of new raw material for the advanced material in coating, automobile chemicals, electricity chemicals and pharmaceutical intermediate.
The EU company of JIN DUN CHEMICAL located at Frankfurt in Germany. It makes us service our customer better in EU, but also takes more valued information for our creation and future developing.
Welcome our customers and friends to visit our company.